A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis

Ozgocmen, 2012, Current concept of spondyloarthritis: special emphasis on early referral and diagnosis, Curr Rheumatol Rep, 14, 409, 10.1007/s11926-012-0274-2 Rudwaleit, 2009, The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis [part II]: validation and final selection, Ann Rheum Dis, 68, 777, 10.1136/ard.2009.108233 Sieper, 2013, Review: nonradiographic axial spondyloarthritis: new definition of an old disease?, Arthritis Rheum, 65, 543, 10.1002/art.37803 Ramonda, 2016, Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey, Arthritis Res Ther, 18, 78, 10.1186/s13075-016-0977-2 Lorenzin, 2023, Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up [Italian arm of the SPondyloArthritis caught early [SPACE] study], Scand J Rheumatol, 1 Kiuru, 2005, Bone stress injuries in asymptomatic elite recruits: a clinical and magnetic resonance imaging study, Am J Sports Med, 33, 272, 10.1177/0363546504267153 Taylor, 2006, Classification criteria for psoriatic arthritis: development of new criteria from a large international study, Arthritis Rheum, 54, 2665, 10.1002/art.21972 Baraliakos, 2021, Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?, Ann Rheum Dis, 80, 469, 10.1136/annrheumdis-2020-218669 Ramiro, 2023, ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update, Ann Rheum Dis, 82, 19, 10.1136/ard-2022-223296 Smolen, 2018, Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force, Ann Rheum Dis, 77, 3, 10.1136/annrheumdis-2017-211734 Lorenzin, 2015, Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab, BMC Musculoskelet Disord, 16, 166, 10.1186/s12891-015-0620-4 Perrotta, 2022, Therapeutic targets for ankylosing spondylitis - recent insights and future prospects, Open Access Rheumatol, 14, 57, 10.2147/OARRR.S295033 Lubrano, 2020, Multimorbidity and comorbidity in psoriatic arthritis - a perspective, Expert Rev Clin Immunol, 16, 963, 10.1080/1744666X.2021.1825941 Lubrano, 2020, Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study, Rheumatol Ther, 7, 825, 10.1007/s40744-020-00229-0 Buch, 2021, Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis, Nat Rev Rheumatol, 17, 17, 10.1038/s41584-020-00541-7 Nagy, 2021, EULAR definition of difficult-to-treat rheumatoid arthritis, Ann Rheum Dis, 80, 31, 10.1136/annrheumdis-2020-217344 Perrotta, 2022, Clinical characteristics of potential “difficult-to-treat” patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort, Rheumatol Ther, 9, 1193, 10.1007/s40744-022-00461-w Wendling, 2023, Is the difficult-to-treat [D2T] concept applicable to axial spondyloarthritis?, Joint Bone Spine, 90, 10.1016/j.jbspin.2022.105512 Dua, 2022, Difficult to treat Spondyloarthritis: patients with a high biologic switch rate and the factors influencing it; a real world as clinic experience [abstract], Arthritis Rheumatol., 74 Lubrano, 2015, Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study, J Rheumatol, 42, 258, 10.3899/jrheum.140811 Coates, 2021, The phenotype of axial Spondyloarthritis: is it dependent on HLA-B27 status?, Arthritis Care Res [Hoboken], 73, 856, 10.1002/acr.24174 Lubrano, 2023, Management of Axial Disease in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations, J Rheumatol, 50, 279, 10.3899/jrheum.220309 Barkham, 2009, Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis, Arthritis Rheum, 60, 946, 10.1002/art.24408 Phillips, 2001, Clinical inertia, Ann Intern Med, 135, 825, 10.7326/0003-4819-135-9-200111060-00012 Lioté, 2023, A prospective survey on therapeutic inertia in psoriatic arthritis [OPTI’PsA], Rheumatology (Oxford), kead262, 10.1093/rheumatology/kead262 Lubrano, 2022, Sequencing of biologic and target synthetic disease-modifying anti-rheumatic drugs in psoriatic arthritis: are we ready to redefine the treatment strategy? A perspective, Rheumatol Ther, 10, 301, 10.1007/s40744-022-00514-0 Bladé, 1998, Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and Haemopoietic stem cell transplantation, Br J Haematol, 102, 1115, 10.1046/j.1365-2141.1998.00930.x Sieper, 2014, Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1, Ann Rheum Dis, 73, 101, 10.1136/annrheumdis-2012-203201 Landewé, 2018, Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study, Lancet., 392, 134, 10.1016/S0140-6736(18)31362-X Sieper, 2013, Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial [ABILITY-1], Ann Rheum Dis, 72, 815, 10.1136/annrheumdis-2012-201766 Poddubnyy, 2012, Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis, Arthritis Rheum, 64, 1388, 10.1002/art.33465 Kiltz, 2012, Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?, Arthritis Care Res (Hoboken), 64, 1415, 10.1002/acr.21688 Dougados, 1991, The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy, Arthritis Rheum, 34, 1218, 10.1002/art.1780341003 Conaghan, 2019, Therapeutic options for targeting inflammatory osteoarthritis pain, Nat Rev Rheumatol, 15, 355, 10.1038/s41584-019-0221-y Aronson, 2004, Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome, Int J Obes Relat Metab Disord, 28, 674, 10.1038/sj.ijo.0802609 Jensen, 2016, Psoriasis and obesity, Dermatology, 232, 633, 10.1159/000455840 McGonagle, 2002, The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy, Arthritis Rheum, 46, 489, 10.1002/art.10125 Lambert, 2016, Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group, Ann Rheum Dis, 75, 1958, 10.1136/annrheumdis-2015-208642 Armstrong, 2020, Comparison of biologics and Oral treatments for plaque psoriasis: a Meta-analysis, JAMA Dermatol, 156, 258, 10.1001/jamadermatol.2019.4029 Webers, 2023, Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis, Ann Rheum Dis, 82, 130, 10.1136/ard-2022-223298 Marzo-Ortega, 2001, Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study, Arthritis Rheum, 44, 2112, 10.1002/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H Benjamin, 2007, Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders, Arthritis Rheum, 56, 224, 10.1002/art.22290 Freemont, 1997, Nerve ingrowth into diseased intervertebral disc in chronic back pain, Lancet, 350, 178, 10.1016/S0140-6736(97)02135-1 de Bruin, 2018, Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohortRMD, Open, 4 Jones, 2020, The prevalence of fibromyalgia in axial spondyloarthritis, Rheumatol Int, 40, 1581, 10.1007/s00296-020-04621-5 Dougados, 2017, Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort, Ann Rheum Dis, 76, 1823, 10.1136/annrheumdis-2017-211596 McGonagle, 2015, ‘MHC-I-opathy’-unified concept for spondyloarthritis and Behçet disease, Nat Rev Rheumatol, 11, 731, 10.1038/nrrheum.2015.147 McGonagle, 2015, ‘MHC-I-opathy’-unified concept for spondyloarthritis and Behçet disease, Nat Rev Rheumatol, 11, 731, 10.1038/nrrheum.2015.147 David, 2023, Real world “poly-refractory RA”: a rare but unmet clinical challenge [abstract], Ann Rheum Dis, 82, 88